Skip to main navigation Skip to search Skip to main content

S-glycosyl primary sulfonamides - A new structural class for selective inhibition of cancer-associated carbonic anhydrases

  • Marie Lopez
  • , Blessy Paul
  • , Andreas Hofmann
  • , Julia Morizzi
  • , Quoc K. Wu
  • , Susan A. Charman
  • , Alessio Innocenti
  • , Daniela Vullo
  • , Claudiu T. Supuran
  • , Sally Ann Poulsen

Research output: Contribution to journalArticleResearchpeer-review

Abstract

In this paper, we present a new class of carbonic anhydrase (CA) inhibitor that was designed to selectively target the extracellular domains of the cancer-relevant CA isozymes. The aromatic moiety of the classical zinc binding sulfonamide CA inhibitors is absent from these compounds and instead they incorporate a hydrophilic mono- or disaccharide fragment directly attached to the sulfonamide group to give S-glycosyl primary sulfonamides (1-10). The inhibition properties of these compounds at the physiologically abundant human CA isozymes I and II and cancer-associated IX and XII were determined, and all compounds had moderate potency with Kis in the micromolar range. We present the crystal structures of anomeric sulfonamides 4, 7, and 10 and the sugar sulfamate drug topiramate in complex with human recombinant CAII. Fromthese structures,we have obtained valuable insights into ligand-protein interactions of these novel carbohydrate-based sulfonamides with CA.

Original languageEnglish
Pages (from-to)6421-6432
Number of pages12
JournalJournal of Medicinal Chemistry
Volume52
Issue number20
DOIs
Publication statusPublished - 22 Oct 2009

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this